FDA recall record

Tizanidine Tablets USP, 4 mg, 150-count tablets per bottle recall — FDA D-238-2013

Labeling Illegible: There is a possibility that the bottle labels do not contain the strength of the product as well as other printing details.

Class IIIclassification
D-238-2013official record ID
Apr 10, 2013report date

Recall record at a glance

Official recordD-238-2013
CategoryDrug Recalls
ClassificationClass III
FDA record statusTerminated
Recalling firmDr. Reddy'S Laboratories
Report dateApr 10, 2013
Recall initiation dateMar 19, 2013
Quantity117,546 bottles
LocationBridgewater, NJ, United States

Official product description

Tizanidine Tablets USP, 4 mg, 150-count tablets per bottle, Rx Only, Mfd. By: Dr. Reddy's Laboratories Limited, Bachepally - 500 090 India; NDC 55111-180-15.

Why the product was recalled

Labeling Illegible: There is a possibility that the bottle labels do not contain the strength of the product as well as other printing details.

Distribution information

Nationwide and Puerto Rico.

How to read the classification

FDA Class III generally covers situations in which use of or exposure to the product is not likely to cause adverse health consequences. The classification displayed here is taken from the FDA enforcement record.

Additional record details

Recall type: Voluntary: Firm initiated. Initial notification: Letter.

What to do next

If you believe you have the recalled product, use the recall number and firm information above to confirm the official notice and follow the instructions issued by the FDA, recalling firm, retailer or product manufacturer. For drugs and medical devices, decisions about treatment or medical care should be discussed with a qualified health professional.

About this record

Recall Lookup USA preserves the most complete source information successfully retrieved. We do not create missing facts or infer affected lots or VINs. The official record may still change, so use the identifier above when verifying current instructions.

FDA source limitation: openFDA enforcement reports are a reference dataset, not a live public-alert or recall-lifecycle service. FDA notes that enforcement-report status may not be updated after classification. Confirm current actions with the FDA, recalling firm or appropriate healthcare professional when relevant.